关于对右心衰竭的普遍定义:正在进行中的工作
Rohit Jogendran1, Chandak Upagupta1, Maya Pankiw1
1University of Toronto, Toronto, Ontario, Canada.
The Canadian journal of cardiology
|February 8, 2025
概括
由于右心室的复杂性,定义右心力衰竭 (RHF) 是一个挑战. 本综述综合了当前的标准,强调了对RHF的一致诊断标准的需要.
科学领域:
- 心脏病学 心脏病学
- 临床医学 临床医学
- 心脏衰竭研究研究
背景情况:
- 右心力衰竭 (RHF) 是一种右心室功能障碍综合征.
- 定义RHF是复杂的,因为右心室的异质性和挑战在特征其结构和功能.
- 现有的文献介绍了在各种临床环境中定义RHF的各种方法.
研究的目的:
- 为了对有关右心力衰竭的文献进行范围审查.
- 综合知识并提取不同临床群体中定义RHF的推标准.
- 确定目前对RHF的定义和诊断方法中的挑战和不一致性.
主要方法:
- 在过去10年的成年人群中搜索了关于右心脏或右心室衰竭的评论,指南和共识陈述.
- 排除了病例报告,重复和研究,重点关注左侧心脏病.
- 根据诊断方式,提取患者群体和定义RHF的定量标准.
主要成果:
- 从最初识别的9487件中,选出了71件物品.
- 大多数经过审查的文献使用了多方面的诊断方法 (临床,心声学,血液学,治疗).
- 对于RHF的命名是可变的,只有40%的文章提供了叙事定义.
结论:
- 一致的标准和对右心力衰竭的普遍定义仍在开发中.
- 射频的异质性需要特定于背景的诊断考虑.
- 需要进行进一步的研究,以建立RHF的标准化诊断标准.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
374
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374
Acute Respiratory Failure-I
162
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
162
Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
Heart Failure Drugs: β-Blockers
311
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
311


